• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较特发性膜性肾病中国成人和儿童肾小球中磷脂酶 A2 受体的染色。

Compared staining of the phospholipase A2 receptor in the glomeruli of Chinese adults and children with idiopathic membranous nephropathy.

机构信息

Department of Nephrology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Kong Jiang Road, 1665, 200092, Shanghai, China.

Department of Nephrology and Rheumatology, Children's Hospital of Shanghai, Shanghai Jiao Tong University, Shanghai, China.

出版信息

Pathol Res Pract. 2019 May;215(5):952-956. doi: 10.1016/j.prp.2019.01.046. Epub 2019 Feb 1.

DOI:10.1016/j.prp.2019.01.046
PMID:30765126
Abstract

BACKGROUND

The identification of the M-type phospholipase A2 receptor (PLA2R) is a breakthrough recognized as a major target for adults with idiopathic membranous nephropathy (IMN). However, the role PLA2R played in pediatric patients with IMN, particularly in Chinese, has yet to be determined.

METHODS

This retrospective study included 187 adult patients and 38 pediatric patients aged 17 years or younger with biopsy proved IMN. The pediatric cohort consisted of 27 children aged from 1 to 12 years and 11 children aged from 13 to 17. Glomerular expression of PLA2R was analyzed in stored, formalin-fixed, paraffin-embedded kidney biopsy sections.

RESULTS

PLA2R staining in glomerular deposits was observed in 82.7% and 42.1% of adult and pediatric patients with IMN, respectively. The PLA2R-positive staining patients with IMN presented with more severe clinical features than PLA2R-negative staining patients in both adult and pediatric cohorts. When compared to the young children patients with IMN, the adolescents exhibited a higher positive rate of PLA2R staining (81.8% versus 25.9%), similar to the adult patients.

CONCLUSION

The clinical features and prevalence of PLA2R positive staining in adolescent patients with IMN were similar to adult patients, suggesting that they probably have a close etiology and pathogenesis. However, most of the young children patients with IMN were PLA2R negative staining, suggesting a different underlying etiology.

摘要

背景

M 型磷脂酶 A2 受体(PLA2R)的鉴定被认为是特发性膜性肾病(IMN)成人患者的主要靶点,这是一项突破性的发现。然而,PLA2R 在儿科 IMN 患者中的作用,尤其是在中国人群中的作用,尚未确定。

方法

本回顾性研究纳入了 187 例成年患者和 38 例年龄在 17 岁及以下的经活检证实的 IMN 儿科患者。儿科患者组包括 27 例 1 至 12 岁儿童和 11 例 13 至 17 岁儿童。在储存的福尔马林固定、石蜡包埋的肾活检切片中分析 PLA2R 在肾小球中的表达。

结果

在分别患有 IMN 的成年和儿科患者中,PLA2R 染色在肾小球沉积物中分别观察到 82.7%和 42.1%。PLA2R 阳性染色的 IMN 患者在成年和儿科患者队列中均表现出比 PLA2R 阴性染色患者更严重的临床特征。与 IMN 的年幼儿童患者相比,青少年患者的 PLA2R 染色阳性率更高(81.8%比 25.9%),与成年患者相似。

结论

青少年 IMN 患者的临床特征和 PLA2R 阳性染色率与成年患者相似,提示它们可能具有密切的病因和发病机制。然而,大多数 IMN 的年幼儿童患者 PLA2R 染色阴性,提示潜在病因不同。

相似文献

1
Compared staining of the phospholipase A2 receptor in the glomeruli of Chinese adults and children with idiopathic membranous nephropathy.比较特发性膜性肾病中国成人和儿童肾小球中磷脂酶 A2 受体的染色。
Pathol Res Pract. 2019 May;215(5):952-956. doi: 10.1016/j.prp.2019.01.046. Epub 2019 Feb 1.
2
M-type phospholipase A receptor (PLAR) glomerular staining in pediatric idiopathic membranous nephropathy.M型磷脂酶A受体(PLAR)在儿童特发性膜性肾病中的肾小球染色
Pediatr Nephrol. 2017 Apr;32(4):713-717. doi: 10.1007/s00467-016-3552-9. Epub 2016 Dec 5.
3
Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.中国单中心回顾性研究:磷脂酶 A2 受体相关和血栓素型 1 域包含 7A 相关特发性膜性肾病的临床和组织学特征。
Med Sci Monit. 2018 Jul 22;24:5076-5083. doi: 10.12659/MSM.909815.
4
Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.特发性膜性肾病患儿中抗M型磷脂酶A2受体抗体
Nephrology (Carlton). 2015 Aug;20(8):572-5. doi: 10.1111/nep.12478.
5
Serum Antibody and Glomerular Antigen of Antiphospholipase A2 Receptor in Chinese Patients with Idiopathic Membranous Nephropathy.特发性膜性肾病患者血清抗磷脂酶 A2 受体抗体与肾小球抗原。
Biomed Res Int. 2020 May 8;2020:1693710. doi: 10.1155/2020/1693710. eCollection 2020.
6
Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.中国特发性膜性肾病患者血栓反应蛋白型 I 域包含蛋白 7A 的循环抗体。
Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1642-1651. doi: 10.2215/CJN.01460217. Epub 2017 Aug 11.
7
Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy.中国膜性肾病患者中针对 M 型磷脂酶 A2 受体和血栓反应素型-1 结构域包含蛋白 7A 的循环抗体。
Int Urol Nephrol. 2019 Aug;51(8):1371-1377. doi: 10.1007/s11255-019-02146-w. Epub 2019 Jun 21.
8
Analysis of Glomerular IgG Subclasses Switch in Idiopathic Membranous Nephropathy Classified by Glomerular Phospholipase A2 Receptor Antigen and Serum Antibody.特发性膜性肾病肾小球磷脂酶 A2 受体抗原和血清抗体分类后肾小球 IgG 亚型转换分析。
Dis Markers. 2021 Aug 30;2021:9965343. doi: 10.1155/2021/9965343. eCollection 2021.
9
Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.肾小球中 M 型磷脂酶 A2 受体的表达增强与原发性膜性肾病患者血清受体抗体相关。
Kidney Int. 2012 Oct;82(7):797-804. doi: 10.1038/ki.2012.209. Epub 2012 Jun 6.
10
Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.特发性膜性肾病预后评估和治疗选择中肾磷脂酶 A2 受体沉积的临床价值:一项回顾性队列研究。
Nephrology (Carlton). 2020 Mar;25(3):219-229. doi: 10.1111/nep.13691. Epub 2020 Jan 20.

引用本文的文献

1
The Clinical Profile and Long-Term Outcome of Children with Membranous Nephropathy, and the Evaluation of Anti-Phospholipase A2 Receptor Antibody Immunohistochemistry in Kidney Biopsy.儿童膜性肾病的临床特征与长期预后,以及肾活检中抗磷脂酶A2受体抗体免疫组化评估
Indian J Nephrol. 2023 Nov-Dec;33(6):432-439. doi: 10.4103/ijn.ijn_228_22. Epub 2023 May 3.
2
How to Choose the Right Treatment for Membranous Nephropathy.如何为膜性肾病选择正确的治疗方法。
Medicina (Kaunas). 2023 Nov 14;59(11):1997. doi: 10.3390/medicina59111997.
3
Pediatric membranous nephropathy: In the novel antigens era.
儿童膜性肾病:在新型抗原时代
Front Immunol. 2022 Aug 9;13:962502. doi: 10.3389/fimmu.2022.962502. eCollection 2022.
4
Idiopathic membranous nephropathy in children: A case report.儿童特发性膜性肾病:一例报告。
World J Clin Cases. 2022 Jun 6;10(16):5387-5393. doi: 10.12998/wjcc.v10.i16.5387.
5
Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era.膜性肾病:PLA2R 时代后的诊断、治疗和监测。
Pediatr Nephrol. 2021 Jan;36(1):19-30. doi: 10.1007/s00467-019-04425-1. Epub 2019 Dec 6.